SKI Market

A+| A| A-|

Indian Indices

Sensex

75,405.91 7.19
( 0.01%)

Global Indices

Nasdaq

50,087.63 373.42
(0.75%)

Dow Jones

7,522.46 57.21
(0.77%)

Hang Seng

61,141.50 -1,512.55
(-2.41%)

Nikkei 225

10,362.65 37.30
(0.36%)

Forex

USD-INR

95.64 0.03
(0.04%)

EUR-INR

112.06 -0.23
(-0.21%)

GBP-INR

129.33 -0.17
(-0.13%)

JPY-INR

0.61 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

43.02

849.69

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.21

Back

artemis electicals & projects ltd

TTK Healthcare standalone net profit declines 37.06% in the December 2025 quarter

Jan 22,2026

Net profit of TTK Healthcare declined 37.06% to Rs 10.53 crore in the quarter ended December 2025 as against Rs 16.73 crore during the previous quarter ended December 2024. Sales rose 2.23% to Rs 209.30 crore in the quarter ended December 2025 as against Rs 204.74 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	209.30	204.74	2
OPM %	3.41	3.75	-
PBDT	23.88	24.70	-3
PBT	21.66	22.59	-4
NP	10.53	16.73	-37

75,405.91 7.19 ( 0.01%)

50,087.63 373.42 (0.75%)

7,522.46 57.21 (0.77%)

61,141.50 -1,512.55 (-2.41%)

10,362.65 37.30 (0.36%)

95.64 0.03 (0.04%)

112.06 -0.23 (-0.21%)

129.33 -0.17 (-0.13%)

0.61 0.00 (-0.10%)